赛马鲁肽
超重
肥胖
医学
内科学
内分泌学
糖尿病
2型糖尿病
利拉鲁肽
作者
W. Timothy Garvey,Matthias Blüher,Cristina Contreras,Melanie J. Davies,Eva Winning Lehmann,Kirsi H. Pietiläinen,Domenica Rubino,Paolo Sbraccia,Thomas A. Wadden,Niels Zeuthen,John Wilding
标识
DOI：10.1056/nejmoa2502081
摘要
Cagrilintide-semaglutide provided significant and clinically relevant body-weight reductions in adults with overweight or obesity, as compared with placebo. (Funded by Novo Nordisk; REDEFINE 1 ClinicalTrials.gov number, NCT05567796.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
识字岭的岭
pluto
大力的灵雁
蓝莓橘子酱
tiptip
王彤
盒子
Sea_U
子车茗
pcr163
Dean
Singularity
风吹麦田
麦子
Winfred
贪玩的秋柔
菠菜
Twonej
GingerF
皖公网安备34019202002308
